Emcure Pharmaceuticals Ltd - Strategic SWOT Analysis Review

December 2021 | 27 pages | ID: E6F4CB073F8EN
GlobalData

Abstracts

Emcure Pharmaceuticals Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – GlobalData’s summarization of the company’s business strategy.
• SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Emcure Pharmaceuticals Ltd (Emcure) is a developer, manufacturer, and markets a range of pharmaceutical products across the world. The company develops and manufactures branded generic products. It also manufactures active pharmaceutical ingredients (APIs) primarily for use in manufacturing of pharmaceutical products. Emcure has presence in all major therapeutic areas, which comprises of cardiology, pain and analgesics, HIV, gynecology, blood related, anti-infective, nephrology, diabetes and cancer among others as well as vitamins, minerals and nutrients products. It has operational presence in Brazil, Dubai, South Africa, Singapore and Nigeria. The company has branch offices in Russia and Morocco. Emcure is headquartered in Pune, Maharashtra, India.

Emcure Pharmaceuticals Ltd Key Recent Developments

Jun 30,2021: Indian pharma companies partner to trial molnupiravir for Covid-19
Apr 28,2021: Merck signs licensing deals with five Indian firms for Oral Covid-19 drug

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Contents

SECTION 1 - ABOUT THE COMPANY

Emcure Pharmaceuticals Ltd - Key Facts
Emcure Pharmaceuticals Ltd - Key Employees
Emcure Pharmaceuticals Ltd - Key Employee Biographies
Emcure Pharmaceuticals Ltd - Major Products and Services
Emcure Pharmaceuticals Ltd - History
Emcure Pharmaceuticals Ltd - Company Statement
Emcure Pharmaceuticals Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Emcure Pharmaceuticals Ltd - Business Description
Emcure Pharmaceuticals Ltd - Corporate Strategy
Emcure Pharmaceuticals Ltd - SWOT Analysis
SWOT Analysis - Overview
Emcure Pharmaceuticals Ltd - Strengths
Emcure Pharmaceuticals Ltd - Weaknesses
Emcure Pharmaceuticals Ltd - Opportunities
Emcure Pharmaceuticals Ltd - Threats
Emcure Pharmaceuticals Ltd - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Emcure Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Emcure Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Emcure Pharmaceuticals Ltd, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Jun 30, 2021: Indian pharma companies partner to trial molnupiravir for Covid-19
Apr 28, 2021: Merck signs licensing deals with five Indian firms for Oral Covid-19 drug

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Emcure Pharmaceuticals Ltd, Key Facts
Emcure Pharmaceuticals Ltd, Key Employees
Emcure Pharmaceuticals Ltd, Key Employee Biographies
Emcure Pharmaceuticals Ltd, Major Products and Services
Emcure Pharmaceuticals Ltd, History
Emcure Pharmaceuticals Ltd, Subsidiaries
Emcure Pharmaceuticals Ltd, Key Competitors
Emcure Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Emcure Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Emcure Pharmaceuticals Ltd, Recent Deals Summary

List Of Figures

LIST OF FIGURES

Emcure Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Emcure Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021